Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9423084 | Brain Research Reviews | 2005 | 5 Pages |
Abstract
Myelin inhibition is considered a constitutive, static, repulsive barrier not reactive to a central nervous system (CNS) lesion. However, recent evidence underlines the existence of considerable add-on axon growth inhibition upon CNS injury. This postlesional, reactive myelin/oligodendrocyte-derived inhibition will require the development of novel screening approaches and therapeutic reagents to promote axonal regeneration.
Keywords
Related Topics
Life Sciences
Neuroscience
Neuroscience (General)
Authors
Jan M. Schwab, Frédéric Bernard, Caroline Moreau-Fauvarque, Alain Chédotal,